GLOBAL ANAESTHESIA, SURGERY AND OBSTETRIC COLLABORATION CIC

Company limited by guarantee

Company Registration Number:
15130421 (England and Wales)

Unaudited statutory accounts for the year ended 30 September 2024

Period of accounts

Start date: 11 September 2023

End date: 30 September 2024

GLOBAL ANAESTHESIA, SURGERY AND OBSTETRIC COLLABORATION CIC

Contents of the Financial Statements

for the Period Ended 30 September 2024

Directors report
Balance sheet
Additional notes
Balance sheet notes
Community Interest Report

GLOBAL ANAESTHESIA, SURGERY AND OBSTETRIC COLLABORATION CIC

Directors' report period ended 30 September 2024

The directors present their report with the financial statements of the company for the period ended 30 September 2024

Directors

The directors shown below have held office during the whole of the period from
11 September 2023 to 30 September 2024

Ms Elizabeth Vincent
Mr Oliver Adebayo
Mr Noel Aruparayil
Mr William Bolton
Dr Ryan Ellis
Dr Pei Ong
Ms Helen Please


The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006

This report was approved by the board of directors on
6 June 2025

And signed on behalf of the board by:
Name: Ms Elizabeth Vincent
Status: Director

GLOBAL ANAESTHESIA, SURGERY AND OBSTETRIC COLLABORATION CIC

Balance sheet

As at 30 September 2024

Notes 13 months to 30 September 2024


£
Current assets
Cash at bank and in hand: 32,173
Total current assets: 32,173
Creditors: amounts falling due within one year: 3 ( 32,713 )
Net current assets (liabilities): (540)
Total assets less current liabilities: (540)
Total net assets (liabilities): (540)
Members' funds
Profit and loss account: (540)
Total members' funds: ( 540)

The notes form part of these financial statements

GLOBAL ANAESTHESIA, SURGERY AND OBSTETRIC COLLABORATION CIC

Balance sheet statements

For the year ending 30 September 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen not to file a copy of the company's profit and loss account.

This report was approved by the board of directors on 6 June 2025
and signed on behalf of the board by:

Name: Ms Elizabeth Vincent
Status: Director

The notes form part of these financial statements

GLOBAL ANAESTHESIA, SURGERY AND OBSTETRIC COLLABORATION CIC

Notes to the Financial Statements

for the Period Ended 30 September 2024

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

    Turnover policy

    Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.

GLOBAL ANAESTHESIA, SURGERY AND OBSTETRIC COLLABORATION CIC

Notes to the Financial Statements

for the Period Ended 30 September 2024

  • 2. Employees

    13 months to 30 September 2024
    Average number of employees during the period 0

GLOBAL ANAESTHESIA, SURGERY AND OBSTETRIC COLLABORATION CIC

Notes to the Financial Statements

for the Period Ended 30 September 2024

3. Creditors: amounts falling due within one year note

13 months to 30 September 2024
£
Accruals and deferred income 32,713
Total 32,713

COMMUNITY INTEREST ANNUAL REPORT

GLOBAL ANAESTHESIA, SURGERY AND OBSTETRIC COLLABORATION CIC

Company Number: 15130421 (England and Wales)

Year Ending: 30 September 2024

Company activities and impact

GASOC CIC was established to encourage healthcare trainees and sub-consultant grade medical professionals to engage responsibly and impact fully in global surgery. We were incorporated under the Companies Act 2006 as a Community Interest Company on 11th September 2023. From September 2023 – 2024, GASOC has impact the world of global surgery in numerous ways, including: - Free and subsidised training opportunities for our global community of member’s - Annual International Conference – Hybrid, held on 23rd September 2023 in Oxford UK and online, attended by individuals across 49 different countries around the globe. This year’s overarching theme on ‘Health Equity in Global Surgery, O&G and Anaesthesia” highlighted the ongoing efforts and challenges towards equitable access to safe surgical, obstetric and anaesthetic care globally and how trainees globally can make a positive impact in these areas. We hosted various international speakers, delivered various workshops and talks, as well as awarding presentation and essay prizes. - Frugal Innovation Skills Course – freely available educational programme, delivered online, comprising of eight asynchronous taught modules covering a range of innovation and research skills for surgeons (and allied specialties such as anaesthesia, obstetrics, and trauma care practitioners). The programme equipped participants with knowledge to find solutions to unmet needs which they can apply to practice in resource constrained settings. The aim is that, after the course, innovation projects will be co-developed and delivered by innovation leaders in low resource environments. - Local and Regional events – including, GASOC Yorkshire Regional Event, held in Leeds in July 2024, to encourage discussion, networking opportunities and increased engagement for trainees interest in global health. - Bi-monthly journal clubs – held virtually addressing research within global anaesthesia, surgery and obstetrics delivered in collaboration with speakers from around the globe. - Research – ongoing collaborative research projects have been developed through our research and innovation working groups. - Collaboration – this year, we have continued to collaborate with individuals and several global organisations including, but not limited to; RCSEd, MedAll, Lifebox, MedTech Foundation, Association of Surgeons in Training, NIHR Global Health Research Unit on Global Surgery, Royal College of Anaesthetists (RCOA), Virtual Reality in Medicine and Surgery (VRiMS), OhanaOne, Diamedica, GynaeFellow, Knowledge for Change and Medical Defence Union (MDU).

Consultation with stakeholders

GASOC CIC’s stakeholders are its global members, organisations which we have collaborated during this year, our active committee and our advisory panel. The directors of GASOC CIC are current or previous committee members, and have an understanding of the day-to-day workings, challenges and potentials for impact within the realm of global health. They are thus passionate about advocating for their global community and regularly seek feedback its stakeholders. In addition to its regular committee meetings, a formal annual general meeting (AGM) is held between the active committee members, board of directors and advisory panel. We regularly ask for verbal and written feedback from our members and have been able to make changes because of this. We encourage collaboration between members, aiming to support sustainable global change and empower future leaders, and have been encouraged to see individuals lead their own initiatives to impact their own regions.

Directors' remuneration

No remuneration was received

Transfer of assets

No transfer of assets other than for full consideration

This report was approved by the board of directors on
6 June 2025

And signed on behalf of the board by:
Name: Ms Elizabeth Vincent
Status: Director